Mingde Biology: Proposes to repurchase 100 million to 200 million yuan of shares

LightningPacketLoss · 2026-03-24T12:01:47+00:00

Mingde Biotechnology announced plans to repurchase shares through centralized bidding, with a repurchase amount between 100 million and 200 million yuan, at a maximum price of 28 yuan per share, expected to repurchase 3.57 million to 7.14 million shares, representing 1.54% to 3.07% of total share capital, with a repurchase period of three months.

LightningPacketLoss

2026-03-24 12:01:47

Abstract generation in progress

Recently, Mingde Biological announced that it plans to repurchase its shares through centralized bidding. The total repurchase amount will not exceed 200 million yuan and will not be less than 100 million yuan. The maximum repurchase price is 28 yuan per share. The expected repurchase volume is between 3.57 million and 7.14 million shares, representing 1.54% to 3.07% of the total share capital. The repurchase period will not exceed three months from the date the board approves the plan.

(Mingde Biological Announcement)

(Editor: Yang Yan, Lin Chen)

Keywords: Healthcare

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.